GT201 Injection in Combination With Teraplizumab Injection for Treatment of Patients With Non-small Cell Lung Cancer

NCT06235242 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
2
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated from a business perspective.

Conditions

Interventions

Sponsor

Grit Biotechnology